NIH-funded research U01 cooperative agreement

Understanding how early skin problems lead to allergies in children

Official title: SUNBEAM Birth Cohort: Deciphering the role of early life skin dysfunction in development of the allergic march

Funded at National Jewish Health · NIH-11187004 · Data updated 2026-11-12

This project looks at how skin issues in babies might lead to other allergies like food allergies and asthma as they grow.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionNational Jewish Health
NIH-funded
Lab location1 site (Denver, United States)
Project startSeptember 6, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$1,308,830
NIH project number5U01AI173502-02
Project IDNIH-11187004 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be infants and young children with eczema, as well as their families, who are interested in understanding the progression of allergic diseases.

Less likely to help

Patients who are adults or do not have a history of allergic diseases in early childhood may not directly benefit from this specific research.

What this research studies

Many young children experience allergic conditions like eczema, food allergies, and asthma, often in a sequence called the "allergic march." We want to understand why some babies with eczema go on to develop more allergies, while others do not. Our team believes that different types of skin inflammation in babies could explain why some are more likely to develop additional allergies. We will explore these specific skin patterns to see how they connect to the development of food allergies and asthma in early childhood.

Why it matters

Potential benefit: This work could help us identify babies at highest risk for developing multiple allergies, allowing for earlier interventions to prevent the "allergic march."

How similar studies have gone: While previous work has identified different types of skin inflammation and their link to allergies in general, this specific project explores their role in the "allergic march" progression in infants, which is largely unexplored.

Where this research is happening

  • National Jewish Health
    Denver, United States
    Active

Researchers

  • Principal investigator: Seibold, Max a — National Jewish Health
  • Study coordinator: Seibold, Max a

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.